KUALA LUMPUR, NOV 8 (Bernama) -- Zenas BioPharma Inc (Zenas), a clinical-stage global biopharmaceutical company, has announced its participation in several upcoming healthcare investor conferences.
Zenas will participate in Guggenheim’s Inaugural Healthcare Innovation Conference on Nov 12 in Boston, Massachusetts, United States (US).
Meanwhile, the company's presentation at the Jefferies London Healthcare Conference will take place on Nov 19 in London, United Kingdom, according to a statement.
Additionally, Zenas will also be presenting at Citi’s 2024 Global Healthcare Conference on Dec 3 in Miami and the Evercore ISI HealthCONx Conference on Dec 4 in Coral Gables, both in the state of Florida, US.
Live webcasts and archived replays of the company’s presentations at the Jefferies, Citi and Evercore conferences can be accessed under “Events and Presentations” in the Investors and Media section of Zenas official website.
Zenas is committed to becoming a leader in the development and commercialisation of inflammation and immunology-directed therapies, aiming to improve the lives of those facing autoimmune and rare diseases.
-- BERNAMA
BERNAMA provides up-to-date authentic and comprehensive news and information which are disseminated via BERNAMA Wires; www.bernama.com; BERNAMA TV on Astro 502, unifi TV 631 and MYTV 121 channels and BERNAMA Radio on FM93.9 (Klang Valley), FM107.5 (Johor Bahru), FM107.9 (Kota Kinabalu) and FM100.9 (Kuching) frequencies.
Follow us on social media :
Facebook : @bernamaofficial, @bernamatv, @bernamaradio
Twitter : @bernama.com, @BernamaTV, @bernamaradio
Instagram : @bernamaofficial, @bernamatvofficial, @bernamaradioofficial
TikTok : @bernamaofficial
